EP0160667A1 - Laser healing method and apparatus - Google Patents

Laser healing method and apparatus

Info

Publication number
EP0160667A1
EP0160667A1 EP84903838A EP84903838A EP0160667A1 EP 0160667 A1 EP0160667 A1 EP 0160667A1 EP 84903838 A EP84903838 A EP 84903838A EP 84903838 A EP84903838 A EP 84903838A EP 0160667 A1 EP0160667 A1 EP 0160667A1
Authority
EP
European Patent Office
Prior art keywords
optical energy
tissue
laser
wavelength
biological tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP84903838A
Other languages
German (de)
French (fr)
Other versions
EP0160667A4 (en
Inventor
Douglas K. Dew
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sonomo Corp
Original Assignee
Sonomo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sonomo Corp filed Critical Sonomo Corp
Publication of EP0160667A1 publication Critical patent/EP0160667A1/en
Publication of EP0160667A4 publication Critical patent/EP0160667A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00491—Surgical glue applicators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017—Electrical control of surgical instruments
    • A61B2017/00132—Setting operation time of a device
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy

Definitions

  • This invention relates generally to methods and apparatus for closing wounds and more particularly, to a metnod and apparatus for applying optical energy to biological tissue whereby the tissue is converted to a collagenous, denatured protein substance which joins severed tissues and closes wounds.
  • suturing has been the accepted technique for rejoining severed tissues and closing wounds.
  • Suturing has been achieved with a surgical needle and suturing thread, and more recently, with a variety of polymeric or metallic staples.
  • the intended function of sutures is to hold the edges of the wounds against one another during healing so as to reduce discomfort, pain, scarring, and the time required for healing.
  • suturing systems since they are applied intermittently along a wound, they permit gaps in the wound between sutures to remain open thereby accepting dirt and bacteria. Moreover, in addition to producing a relatively high risk of infection and tissue rejection, such gaps between sutures are eventually filled in by keloid, which results in disfiguration and scarring. In addition, inflamation often results from the foreign body presence of the suture material.
  • sutures may slip in an axial direction thereby permitting relative motion between the tissues which are desired to be joined, and may loosen before the healing process has advanced sufficiently to maintain a tight closure of a wound.
  • sutures must frequently be removed and replaced, thereby requiring multiple visits to a physician.
  • a wound closure system which is uniform throughout the length of a wound.
  • cauterization and cryogenic techniques have been developed to reduce the flow of blood in an open wound, or a surgically-induced incision.
  • cauterization is achieved by using intense heat to sear and seal the open ends of the tissues, such as vessels and capillaries.
  • heat is generated by resistance heating of a metallic probe which is subsequently applied to the tissue to be cauterized.
  • undesired blood flow is discontinued by applying a cryogenic temperature which freezes the tissue.
  • the medical field has utilized high-intensity optical energy generated by one or more lasers to achieve cauterization which limits blood flow. In such known laser systems, the optical energy is applied in sufficient quantity to sear or burn the vessels.
  • Laser cauterization is illustratively described in U.S. Patent No. 4,122,853 to Michael R. Smith. These techniques, however, destroy the surrounding tissue leading to longer healing times, infection, and scarring.
  • Optical energy generated by lasers has been applied in recent times to various medical and surgical purposes because the monochromatic and coherent nature of the light generated by lasers has been shown to have absorbency characteristics which vary with the nature of the illuminated tissue. Thus, for a given tissue type, the laser light may propagate
  • the extent to which the tissue is heated, and ultimately destroyed depends on the extent to which it absorbs the optical energy.
  • the laser light be essentially transmissive in tissues which are desired not to be affected, and absorbed by the tissues which are to be affected.
  • the optical energy not be absorbed by the water or blood, thereby permitting the laser energy to be directed specifically to the tissues desired to be affected.
  • Such selective absorption also permits substantial time saving during an operation by obviating the need for cleaning and drying the operating field.
  • optical energy can be delivered to the tissues desired to be operated upon in a precise location and at predeter inable energy levels.
  • the precision with which the laser energy can be directed is enhanced by its ability to be guided by known thin optical fibers which permit the optical energy to be utilized within a body without requiring large incisions or to be inserted into the body through an endoscope.
  • the optical fibers which conduct the laser-generated optical energy for performing the operation can be combined with other optical fibers which conduct light in the visible range, and further optical fibers which are of the image-transmissive type such that a surgeon may view and control an operation which is occurring within a body.
  • Ruby and argon lasers which are known to emit energy in the visible portion of the electromagnetic spectrum have been used successfully; particularly in the field of ophthalmology to reattach retinas to the underlying choroidea and to treat glaucoma by perforating anterior portions of the eye to relieve intraoccular pressure.
  • the ruby laser energy has a wavelength of 0.694 micrometers and, thus, appears red.
  • the argon laser emits energy at 0.488 and 0.515 micrometers, thus, appearing blue-green.
  • the ruby and argon laser beams are minimally absorbed by water, such as tissue water, but are
  • CO-CO- gas laser Another type of laser currently in surgical use is the carbon dioxide -CO-) gas laser which emits a beam which is intensely absorbed by water.
  • the wavelength of the CO- laser is 10.6 micrometers and therefore lies in the invisible, far infrared region of the electro-magnetic spectrum.
  • FIG. 1A shows that the absorption of energy by water in this part of the spectrum is so great that it is absorbed independently of tissue color by all soft tissues having a high water content.
  • the C0 2 laser makes an excellent surgical scalpel and vaporizer. Since it is so completely absorbed, its depth of penetration is shallow and can be precisely controlled with respect to the surface of the tissue being operated upon.
  • the C0 2 laser is frequently used for neuorological surgery where it is used to vaporize or coagulate neural tissue with minimal thermal damage to underlying tissues.
  • the fourth commonly used type of laser is the neodymium doped yttrium-aluminum-garnet (Nd.YAG) laser.
  • the Nd.YAG laser has a predominant mode of operation at a wavelength of 1.06 micrometers in the near infrared region of the electromagnetic spectrum.
  • Reference to Fig. IB shows that the Nd.YAG emission at 1 micrometers wavelength is absorbed to a greater extent by blood than by water making it useful for coagulating large bleeding vessels.
  • the Nd:YAG at 1.06 ⁇ m laser energy has, for example, been transmitted through endoscopes to treat a variety of gastrointestinal bleeding lesions, such as esophogeal varices, peptic ulcers, and arteriovenous anomolies.
  • ⁇ O biological tissue into a collagenous substance for facilitating healing and wound closure.
  • a monochromatic beam of optical energy is generated at a wavelength in a range between 1.2 micrometers and 1.4 micrometers. Severed segments of a wound or tissue structure are brought into close proximity and a beam of optical energy is guided to the area of the juncture. Upon being illuminated by the beam of optical energy, the tissue in the vicinity of the wound is converted to a denatured proteinaceous collagenous substance which forms a biological glue which closes the wound.
  • the intensity of the optical energy is controlled such that the rate at which such optical energy is absorbed by the tissue in the vicinity of the wound and converts optical energy into thermal is within a range bounded by a minimum absorption rate at which the tissue is converted to a collagenous substance and a maximum absorption rate above which the water contained in the tissue boils.
  • the intensity of the optical energy is controlled by attenuating the monochromatic beam in any of several known ways.
  • the optical energy itself may be generated by a laser.
  • the laser is of the Nd.YAG type which is operated at a secondary wavelength of approximately 1.32 micrometers. Ordinarily such NdrYAG lasers operate at a fundamental wavelength of 1.06 micrometers.
  • the invention not be limited to the particular wavelength of 1.32 micrometers or to a Nd.YAG lasing medium. It is a significant aspect of the invention that the particular wavelength of the optical energy be selected such that the optical energy is propagated without substantial attenuation through water and/or blood, but be absorbed in the biological tissue required to be repaired. Such substantially unattenuated transmission through water and blood simplifies surgical procedures by obviating the need for operating in a dry, clean field.
  • the optical energy is produced by a source, illustratively a laser, having a wavelength between the above-noted 1.2 and 1.4 micrometers.
  • the arrangement is further provided with a guide for directing the beam of optical energy to the wound in the tissue. Moreover, the arrangement is provided with a controller for controlling the intensity of the emitted optical energy. The energy is controlled to a level above which the tissue in the vicinity of the wound is converted to the collagenous substance, but not sufficient to boil water in the tissue being repaired.
  • the arrangement is further provided with a lens which is adapted to produce a predeterminable divergence or convergence in the beam of optical energy as it is emitted from the optical arrangement.
  • the arrangement is provided with a distance measuring device whereby the size of the illuminated spot which is produced on the wound is predeterminable notwithstanding that the optical energy beam has a divergence characteristic upon being emitted.
  • a marker beam of visible light is provided to illuminate and define the region in the wound where the beam of optical energy is to be applied.
  • a marker beam is known for use in arrangements where, as here, the operating beam of optical energy is in the invisible region of the electromagnetic spectrum.
  • a Nd.YAG laser beam which is tuned or is tunable to 1.32 microns is provided with a lens to focus the emitted beam into an optical fiber.
  • the flexible optical fiber is then provided with a shutter and timer on a foot or hand operated switch, and is provided with a hand-piece for manual manipulation of the beam to the desired tissue.
  • Various parameters such as power, beam spot size, time exposure, and laser mode are adjusted according to the desired usage.
  • a microprocesser is further provided for sorting information relating to these parameters.
  • Figs. 1A and IB are graphs of the absorbance of optical energy by water and blood, respectively, plotted against the wavelength of applied energy;
  • Fig. 2 is a block and schematic diagram of a laser surgical system for use in accordance with the invention.
  • Fig. 3 is a schematic side view of a hand piece showing beam divergence to produce a beam spot size which varies with distance.
  • Biological tissue comprises cell layers in a protein framework for tensile strength. All proteins are amino acids which have side chains which are dissolvable either in water or fat.
  • Naturation is a process wherein the amino acids fold over, always in the same configuration for each protein type, when the protein leaves the interior of a cell and is confronted with tissue water. In which case, the hydrophobic portion of a side chain folds to the interior of the molecule.
  • the proteinaceous components of the tissue can be unfolded or denatured by the application of heat.
  • optical energy from a laser is applied to bring the temperature of biological tissue somewhere above room temperature, but below the boiling point of water; preferably above 45 degrees centigrade and particularly at about 60-70 degrees.
  • Collagen a major source of protein in the body, is denatured by application of energy so as to go into solution and form a "biological glue" to seal a lesion, anastomize a severed vessel, or reconstruct damaged tissue.
  • biological glue When the source of heat is removed, the proteins begin to re-nature and form an approxiamate replication of the prior tissue structure. As the body heals, the so-called "biological glue" will be
  • SUBSTIT E SHEET reabsorbed and replaced by natural tissue. It should be noted that the term lesion as used herein denotes a wound, whether formed accidentally, intentionally, or by biological processes.
  • the application of heat, to form a collagenous seal to immediately close a lesion or anastomize a severed vessel has several other advantages. It accelerates healing time because blood supply to the effected tissue can be re-established immediately after operation. Moreover, little or no scarring is produced because no sutures are required. Sutures lead to destruction of tissue, allow the inclusion of foreign material in a wound thereby causing inflammation and/or infection, and permits gaps which are too wide for the body's natural rebuilding mechanism to bridge. Scar tissue is consequently generated as a result of a higher ratio of structural protein, i.e. collagen, to living cells in the vicinity of the lesion.
  • structural protein i.e. collagen
  • Optical energy is converted to heat in tissue which absorbs energy at that wavelength.
  • Reference to Fig. IB shows that light in the visible range is readily absorbed by pigmented tissue. Whereas light emitted in the far infrared, such as that emitted by a carbon dioxide laser, is highly absorbed in both water and blood.
  • the Nd:YAG laser in current use, emits energy primarily a wavelength at 1.06 micrometers and has more absorbance in blood than in water. This, therefore, requires that the operating field be cleared of blood which would absorb applied energy.
  • Formation of a "biological glue" in order to effect repair of GI tract tissue, form skin wound closures, and repair and reconstruct tissue such as reproductive tissue, tendons, and vascular tissue requires optical energy having a wavelength which is relatively unattenuated in water and blood in order to penetrate through a thick layer of tissue at low power.
  • optical energy having a wavelength of 1.2 to 1.4 micrometers is relatively poorly absorbed by both water and blood. Moreover, the differential in absorptivity between water and blood is not so great as to cause one type to preferentially absorb optical energy in this
  • OMPI range In a particularly advantageous embodiment of the invention a commercially available Nd:YAG laser is used to generate optical energy having a wavelength of about 1.32 micrometers.
  • Fig. 2 is a highly schematic representation of a laser surgical system for use in accordance with the invention.
  • Laser 20 is preferably of the Nd:YAG crystalline variety wherein a yttrium-aluminum-garnet (YAG) rod is doped with Nd ions as the active light-producing element.
  • YAG yttrium-aluminum-garnet
  • laser 20 includes a resonant cavity for amplifying the emitted light and pumping means, such as a dc Krypton arc lamp, for supplying energy to create a population inversion of the normal energy state of Nd ions. Such a population inversion results in the stimulated emission of light in accordance with known laser principles.
  • Nd:YAG lasers will always operate at a first and predominant mode of emission at a wavelength of approximately 1.06 micrometers. Nd:YAG lasers also emit light at a secondary wavelength of approximately 1.32 micrometers. Proper utilization of this secondary mode if laser operation requires the dominant emission, which has a greater amplitude than the secondary emission, to be suppressed. Typically, the peak power output at this secondary emission level is 20-30% of the continuous wave peak power output at the dominant level. It is the secondary wavelength that is utilized in the method and apparatus of the invention.
  • laser 20 includes a power station for activiating the pumping arc lamp and cooling means for the laser.
  • a suitable Nd:YAG laser for use in this invention is produced by Control Laser Corporation, which is presently located at 11222 Astronaut Boulevard, Orlando Florida 32809.
  • a lens 21 is provided to focus the emerging coherent light beam from laser 20 into an optical fiber 22.
  • Lens 21 may comprise a system of lenses.
  • Optical fiber 22 can be of any known type, which efficiently transmits the desired wavelength.
  • Optical fiber 22 provides a flexible conduit for guiding the optical energy from the laser into a hand-piece 23 which is manipulable by the physician.
  • a shutter 24 is located, preferably, between laser 20 and lens 21.
  • Hand-piece 23 contains a shutter switch 25 which controls release of the laser energy and which may be actuated by either the hand or the foot of the operator.
  • a timer 26 is provided to control the shutter and, thereby, the duration of energy exposure.
  • Hand-piece 23 may include a lens for focusing or defocusing the beam.
  • hand-piece 23 includes means to enable the physician to set the working distance between the tissue to be irradiated and the distalmost end of the optical fiber of lens.
  • a sliding scale 26 which cooperates with a protective case 27 on the end of the optical fiber 28 controls the working distance, and hence, the diameter of the beam spot.
  • the divergence of the beam is used to control the diameter as the distance between the distalmost end of the fiber and the tissue is increased or decreased.
  • the following electro-optical parameters require proper adjustment for each type of tissue: wavelength, spot or beam size, power, time exposure, and mode or beam geometry.
  • the thermal effects on the tissue can be controlled by proper selection of the electro-optical parameters.
  • Power density measures the energy concentration of the applied light beam and is typically expressed in watts per square centimeter area of the applied beam spot. Power density is directly related to the amount of heat that will be produced at a given absorptivity. If the wavelength of the applied beam is poorly absorbed, more heat can be generated by increasing the time of tissue exposure to the applied beam. Radiant exposure, expressed in joules per square centimeter, is a measure of the power density multiplied by the exposure time.
  • Means which are well known it the art are used to control the power output of laser 20.
  • the power delivered to the tissue surface should be maintained under 10 watts for purposes of tissue reconstruction by laser 20 as described herein.
  • the object is to deliver a specific amount of energy
  • TE specific ⁇ ally, a more concentrated beam results which can be used for cutting purposes at higher power output or for achieving very small beam spot size for tissue reconstruction.
  • multimode transmission can be used for tissue reconstruction, but the beam spot size can not be as finely focused as the TEMoo mode. However, it the beam is defocused, less power is delivered per unit area.
  • data relating to appropriate settings of electro-optical parameters for various tissue types can be coded on a computer memory device, such as floppy disc or programmable read-only memory computer chip.
  • This control unit 40 can be provided to adjust automatically the time exposure, power level, and display the proper spot size upon input of tissue type and the operating conditions by the physician or surgeon.
  • a marker laser 30, illustratively a low-power helium-neon laser is coaligned with the infrared beam of the laser 20.
  • Laser 30 can be of any type which emits radiation in the visible range of the electromagnetic spectrum.
  • the power rating of the helium-neon marker laser 30 is between 1-5 mWatts.
  • Marker laser 30 can be arranged so that its focal point coincides with that of the main operating laser 20 by any known technique.
  • an auxiliary source of optical energy 50 can be incorporated into the apparatus to emit radiation having a wavelength which is intensely absorbed by biological tissue.
  • a carbon dioxide laser of any known type, would be a suitable auxiliary source.
  • Source 50 is also preferrably arranged so as to have its output beam coincide with the beam from marker laser 30.
  • the 1.06 micrometer wavelength of the Nd:YAG laser 20 can be selected by means which are all well known in the art for purposes of tissue coagulation and wound hemostasis, as desired.
  • the apparatus of Fig. 2 is used for skin closure at a lesion site.
  • the tissue edges of the lesion are brought into close approximation by manual manipulation, for example.
  • Hand-piece 23 is positioned above the lesion at such a distance as to produce the desired beam spot size.
  • the power, spot size, and time exposure are adjusted so as to heat the tissue above 45 degrees centigrade, but below the boiling point of water (100 degrees centigrade).
  • Typical spot sizes range from 0.1 mm to 1.0 mm for levels of power delivered to the tissue ranging from 1 to 5 watts, and time durations ranging from 0.05 to 5.0 seconds.
  • the tissue at the lesion site is heated to a temperature sufficient to cause denaturization of the tissue proteins to the depth necessary to reconstruct the tissue in the lesion irrespective of whether the operating field is blody or wet.
  • These same electro-optical parameters may be applied to the reconstruction of many soft tissues such as vascular structures, tendon, vas deferens, fallopian tubes, gastro-intestional tract, dura, and sclera.
  • cartilage and typanic membranes can be repaired in accordance with the invention described hereinabove.
  • the laser energy can be transmitted to the patient treatment site by an articulated arm with mirrors or it can be transmitted to the interior of a patient by endoscope.
  • materials other than neodymium-doped crystalline yttrium-aluminum-garnet can be used as a lasing medium to generate optical energy at the desired wavelengths.

Abstract

L'énergie optique émise par un laser est utilisée pour effectuer la cicatrisation de blessures et la reconstruction de tissus biologiques. De l'énergie optique est appliquée pour produire un échauffement des tissus biologiques jusqu'à un degré où se produit la dénaturation des protéines des tissus, de sorte que les éléments collagènes des tissus forment une "colle biologique" qui scelle immédiatement et/ou reconstruit le tissu chauffé. Cette colle collagène est ensuite réabsorbée par le corps pendant le processus de cicatrisation. Dans un procédé et un dispositif particulièrement avantageux, on provoque l'émission d'un faisceau laser au Nd:YAG (20) accordé sur une longueur d'onde de 1,32 micromètres vers un obturateur (24), une lentille (21), une fibre optique (22) et une poignée (23), à de faibles niveaux de puissance pour obtenir une pénétration des tissus en profondeur, avec un effet thermique réduit. Un laser auxiliaire (50) et un laser marqueur (30) sont également utilisés avec le laser au Nd:YAG. Le dispositif est commandé par une unité de commande (40) et par un cadenceur (26) actionné par un commutateur (25).The optical energy emitted by a laser is used to heal wounds and reconstruct biological tissue. Optical energy is applied to produce heating of the biological tissues to a degree where the denaturation of the tissue proteins occurs, so that the collagen elements of the tissues form a "biological glue" which immediately seals and / or reconstructs the heated fabric. This collagen glue is then reabsorbed by the body during the healing process. In a particularly advantageous method and device, the emission of a laser beam with Nd: YAG (20) tuned on a wavelength of 1.32 micrometers is caused towards a shutter (24), a lens (21). , an optical fiber (22) and a handle (23), at low power levels to obtain deep tissue penetration, with a reduced thermal effect. An auxiliary laser (50) and a marker laser (30) are also used with the Nd: YAG laser. The device is controlled by a control unit (40) and by a timer (26) actuated by a switch (25).

Description

Laser Healing Method and Apparatus
Background of the Invention
This invention relates generally to methods and apparatus for closing wounds and more particularly, to a metnod and apparatus for applying optical energy to biological tissue whereby the tissue is converted to a collagenous, denatured protein substance which joins severed tissues and closes wounds.
Historically, suturing has been the accepted technique for rejoining severed tissues and closing wounds. Suturing has been achieved with a surgical needle and suturing thread, and more recently, with a variety of polymeric or metallic staples. The intended function of sutures is to hold the edges of the wounds against one another during healing so as to reduce discomfort, pain, scarring, and the time required for healing.
It is the problem with known suturing systems that since they are applied intermittently along a wound, they permit gaps in the wound between sutures to remain open thereby accepting dirt and bacteria. Moreover, in addition to producing a relatively high risk of infection and tissue rejection, such gaps between sutures are eventually filled in by keloid, which results in disfiguration and scarring. In addition, inflamation often results from the foreign body presence of the suture material.
It is an additional disadvantage of conventional sutures that they may slip in an axial direction thereby permitting relative motion between the tissues which are desired to be joined, and may loosen before the healing process has advanced sufficiently to maintain a tight closure of a wound. Thus, sutures must frequently be removed and replaced, thereby requiring multiple visits to a physician. There is a need, therefore, for a wound closure system which is uniform throughout the length of a wound.
A variety of cauterization and cryogenic techniques have been developed to reduce the flow of blood in an open wound, or a surgically-induced incision. Generally, cauterization is achieved by using intense heat to sear and seal the open ends of the tissues, such as vessels and capillaries. In known cauterization systems, heat is generated by resistance heating of a metallic probe which is subsequently applied to the tissue to be cauterized. Alternatively, undesired blood flow is discontinued by applying a cryogenic temperature which freezes the tissue. More recently, the medical field has utilized high-intensity optical energy generated by one or more lasers to achieve cauterization which limits blood flow. In such known laser systems, the optical energy is applied in sufficient quantity to sear or burn the vessels. Laser cauterization is illustratively described in U.S. Patent No. 4,122,853 to Michael R. Smith. These techniques, however, destroy the surrounding tissue leading to longer healing times, infection, and scarring.
Recent advances in the state of the art have produced cauterization with the use of ultrasonic energy which is converted to mechanical vibrations through a knife. Such a rapidly vibrating knife simultaneously cuts and closes off severed vessels. A system of the ultrasonic vibrational type is described in U.S. Patent No. 3,794,040 which issued to Balamuth. In the known system, ultrasonic energy is applied to create heating of the vessels desired to be cauterized above room temperature, but below a temperature at which such vessel would sear. The heat thus produced causes hemeostasis, by denaturing of the proteins in the tissue to form a collagenous substance which performs as a glue to achieve the closure or bond. This technique, however, has not gained wisespread use for delicate surgery because it requires bringing a vibrating probe into contact with the tissue to be affected. Moreover, ultrasonic energy is nonpreferentially absorbed and affects all of the surrounding tissue.
Optical energy generated by lasers has been applied in recent times to various medical and surgical purposes because the monochromatic and coherent nature of the light generated by lasers has been shown to have absorbency characteristics which vary with the nature of the illuminated tissue. Thus, for a given tissue type, the laser light may propagate
O P through the tissue, substantially unattenuated, or may be almost entirely absorbed. Of course, the extent to which the tissue is heated, and ultimately destroyed, depends on the extent to which it absorbs the optical energy. It is generally preferred that the laser light be essentially transmissive in tissues which are desired not to be affected, and absorbed by the tissues which are to be affected. For example, when using lasers in fields which are wet with blood or water, it is desired that the optical energy not be absorbed by the water or blood, thereby permitting the laser energy to be directed specifically to the tissues desired to be affected. Such selective absorption also permits substantial time saving during an operation by obviating the need for cleaning and drying the operating field.
It is a further known advantage of a laser system that the optical energy can be delivered to the tissues desired to be operated upon in a precise location and at predeter inable energy levels. The precision with which the laser energy can be directed is enhanced by its ability to be guided by known thin optical fibers which permit the optical energy to be utilized within a body without requiring large incisions or to be inserted into the body through an endoscope. The optical fibers which conduct the laser-generated optical energy for performing the operation can be combined with other optical fibers which conduct light in the visible range, and further optical fibers which are of the image-transmissive type such that a surgeon may view and control an operation which is occurring within a body.
Ruby and argon lasers which are known to emit energy in the visible portion of the electromagnetic spectrum have been used successfully; particularly in the field of ophthalmology to reattach retinas to the underlying choroidea and to treat glaucoma by perforating anterior portions of the eye to relieve intraoccular pressure. The ruby laser energy has a wavelength of 0.694 micrometers and, thus, appears red. The argon laser emits energy at 0.488 and 0.515 micrometers, thus, appearing blue-green. The ruby and argon laser beams are minimally absorbed by water, such as tissue water, but are
OMP intensely absorbed by the blood chromagen hemoglobin. Thus the ruby and argon laser energy is poorly absorbed by nonpigmented tissue such as the cornea, lens, and vitreous humor of the eye, but is preferentially absorbed by the pigmented retina where it can then exert a thermal effect.
Another type of laser currently in surgical use is the carbon dioxide -CO-) gas laser which emits a beam which is intensely absorbed by water. The wavelength of the CO- laser is 10.6 micrometers and therefore lies in the invisible, far infrared region of the electro-magnetic spectrum. Reference to FIG. 1A shows that the absorption of energy by water in this part of the spectrum is so great that it is absorbed independently of tissue color by all soft tissues having a high water content. Thus the C02 laser makes an excellent surgical scalpel and vaporizer. Since it is so completely absorbed, its depth of penetration is shallow and can be precisely controlled with respect to the surface of the tissue being operated upon. The C02 laser is frequently used for neuorological surgery where it is used to vaporize or coagulate neural tissue with minimal thermal damage to underlying tissues.
The fourth commonly used type of laser is the neodymium doped yttrium-aluminum-garnet (Nd.YAG) laser. The Nd.YAG laser has a predominant mode of operation at a wavelength of 1.06 micrometers in the near infrared region of the electromagnetic spectrum. Reference to Fig. IB shows that the Nd.YAG emission at 1 micrometers wavelength is absorbed to a greater extent by blood than by water making it useful for coagulating large bleeding vessels. The Nd:YAG at 1.06 μm laser energy has, for example, been transmitted through endoscopes to treat a variety of gastrointestinal bleeding lesions, such as esophogeal varices, peptic ulcers, and arteriovenous anomolies.
It is characteristic of all of these known uses of laser energy that the tissue thus exposed is destroyed by searing, charring, or vaporization. It is therefore an object of this invention to utilize laser energy either to heal or recon¬ struct tissue, rather than to destroy tissue. It is also an object of this invention to replace surgical sutures or staples in wound closures by a technique which creates an immediate seal of the severed tissue, is faster, requires minimal surgical manipulation of tissue, reduces possibility of infection, and minimizes scarring.
It is another object of this invention to use the body's own tissue elements to form a seal or a bond between severed elements of tissue.
It is still another object to use electro-optical energy to form a collagenous bonding tissue which is similar in composition to the tissue from which it is produced.
It is yet a further object of the invention to provide wound closure and reconstruction, inter alia, of the following tissues: skin, nerve fiber, vascular tissues, reproductive tissue structures such as vas deferens or fallopian tubes, gastro-intestinal tract, eye tissues, and tendons.
It is also a further object of the invention to provide the wound closure and reconstruction of the above-identified tissues quickly, with little or no scarring, and with minimal risk of infection.
It is a still further object of the invention to use laser energy having a low absorbance in a bloody or wet field to increase the utility of the laser within the normal operating fields.
It is still another object of the invention to utilize a laser energy which is not preferentially absorbed by either blood or water, thereby enabling a low temperature thermal effect to be produced upon a desired tissue with deeper penetration and with substantially reduced risk of damaging neighboring tissues.
It is also another object of the invention to provide a laser apparatus which is automated and portable for effecting closure of wounds and reconstruction of tissues.
Summary of the Invention
The foregoing and other objects are achieved by this invention which provides a method and apparatus for converting
^ O biological tissue into a collagenous substance for facilitating healing and wound closure. In accordance with a method aspect of the invention, a monochromatic beam of optical energy is generated at a wavelength in a range between 1.2 micrometers and 1.4 micrometers. Severed segments of a wound or tissue structure are brought into close proximity and a beam of optical energy is guided to the area of the juncture. Upon being illuminated by the beam of optical energy, the tissue in the vicinity of the wound is converted to a denatured proteinaceous collagenous substance which forms a biological glue which closes the wound.
The intensity of the optical energy is controlled such that the rate at which such optical energy is absorbed by the tissue in the vicinity of the wound and converts optical energy into thermal is within a range bounded by a minimum absorption rate at which the tissue is converted to a collagenous substance and a maximum absorption rate above which the water contained in the tissue boils. Generally the intensity of the optical energy is controlled by attenuating the monochromatic beam in any of several known ways. The optical energy itself may be generated by a laser. Preferably, the laser is of the Nd.YAG type which is operated at a secondary wavelength of approximately 1.32 micrometers. Ordinarily such NdrYAG lasers operate at a fundamental wavelength of 1.06 micrometers.
It is intended that the invention not be limited to the particular wavelength of 1.32 micrometers or to a Nd.YAG lasing medium. It is a significant aspect of the invention that the particular wavelength of the optical energy be selected such that the optical energy is propagated without substantial attenuation through water and/or blood, but be absorbed in the biological tissue required to be repaired. Such substantially unattenuated transmission through water and blood simplifies surgical procedures by obviating the need for operating in a dry, clean field.
In accordance with the invention, the optical energy is produced by a source, illustratively a laser, having a wavelength between the above-noted 1.2 and 1.4 micrometers.
SUBSTITUTE SHEET The arrangement is further provided with a guide for directing the beam of optical energy to the wound in the tissue. Moreover, the arrangement is provided with a controller for controlling the intensity of the emitted optical energy. The energy is controlled to a level above which the tissue in the vicinity of the wound is converted to the collagenous substance, but not sufficient to boil water in the tissue being repaired.
In one embodiment of the invention, the arrangement is further provided with a lens which is adapted to produce a predeterminable divergence or convergence in the beam of optical energy as it is emitted from the optical arrangement. In this arrangement, the arrangement is provided with a distance measuring device whereby the size of the illuminated spot which is produced on the wound is predeterminable notwithstanding that the optical energy beam has a divergence characteristic upon being emitted.
In another embodiment of the invention, a marker beam of visible light is provided to illuminate and define the region in the wound where the beam of optical energy is to be applied. Such a marker beam is known for use in arrangements where, as here, the operating beam of optical energy is in the invisible region of the electromagnetic spectrum.
In a surgical system or apparatus for performing the method of the invention described above, a Nd.YAG laser beam which is tuned or is tunable to 1.32 microns is provided with a lens to focus the emitted beam into an optical fiber. The flexible optical fiber is then provided with a shutter and timer on a foot or hand operated switch, and is provided with a hand-piece for manual manipulation of the beam to the desired tissue. Various parameters such as power, beam spot size, time exposure, and laser mode are adjusted according to the desired usage. A microprocesser is further provided for sorting information relating to these parameters.
Brief Description of the Drawings
These and other objects, features and advantages of the invention are more readily understood when read in conjunction
-* 0RE
O P WIP with the following drawings wherein:
Figs. 1A and IB are graphs of the absorbance of optical energy by water and blood, respectively, plotted against the wavelength of applied energy;
Fig. 2 is a block and schematic diagram of a laser surgical system for use in accordance with the invention; and
Fig. 3 is a schematic side view of a hand piece showing beam divergence to produce a beam spot size which varies with distance.
Detailed Description of the Invention
Biological tissue comprises cell layers in a protein framework for tensile strength. All proteins are amino acids which have side chains which are dissolvable either in water or fat. Naturation is a process wherein the amino acids fold over, always in the same configuration for each protein type, when the protein leaves the interior of a cell and is confronted with tissue water. In which case, the hydrophobic portion of a side chain folds to the interior of the molecule. The proteinaceous components of the tissue can be unfolded or denatured by the application of heat.
It has been discovered that application of optical energy to biological tissue, in an amount sufficient to generate enough heat to denature the proteinaceous components, can be used to cause the bod rs own tissues to substantially reproduce the prior tissue structure at a lesion or severed tissue site. In a particularly advantageous embodiment of the invention, optical energy from a laser is applied to bring the temperature of biological tissue somewhere above room temperature, but below the boiling point of water; preferably above 45 degrees centigrade and particularly at about 60-70 degrees. Collagen, a major source of protein in the body, is denatured by application of energy so as to go into solution and form a "biological glue" to seal a lesion, anastomize a severed vessel, or reconstruct damaged tissue. When the source of heat is removed, the proteins begin to re-nature and form an approxiamate replication of the prior tissue structure. As the body heals, the so-called "biological glue" will be
SUBSTIT E SHEET reabsorbed and replaced by natural tissue. It should be noted that the term lesion as used herein denotes a wound, whether formed accidentally, intentionally, or by biological processes.
As can be appreciated, the application of heat, to form a collagenous seal to immediately close a lesion or anastomize a severed vessel has several other advantages. It accelerates healing time because blood supply to the effected tissue can be re-established immediately after operation. Moreover, little or no scarring is produced because no sutures are required. Sutures lead to destruction of tissue, allow the inclusion of foreign material in a wound thereby causing inflammation and/or infection, and permits gaps which are too wide for the body's natural rebuilding mechanism to bridge. Scar tissue is consequently generated as a result of a higher ratio of structural protein, i.e. collagen, to living cells in the vicinity of the lesion.
Optical energy is converted to heat in tissue which absorbs energy at that wavelength. Reference to Fig. IB shows that light in the visible range is readily absorbed by pigmented tissue. Whereas light emitted in the far infrared, such as that emitted by a carbon dioxide laser, is highly absorbed in both water and blood. The Nd:YAG laser, in current use, emits energy primarily a wavelength at 1.06 micrometers and has more absorbance in blood than in water. This, therefore, requires that the operating field be cleared of blood which would absorb applied energy. Formation of a "biological glue" in order to effect repair of GI tract tissue, form skin wound closures, and repair and reconstruct tissue such as reproductive tissue, tendons, and vascular tissue requires optical energy having a wavelength which is relatively unattenuated in water and blood in order to penetrate through a thick layer of tissue at low power.
It was discovered that optical energy having a wavelength of 1.2 to 1.4 micrometers is relatively poorly absorbed by both water and blood. Moreover, the differential in absorptivity between water and blood is not so great as to cause one type to preferentially absorb optical energy in this
-gtϊ EA
OMPI range. In a particularly advantageous embodiment of the invention a commercially available Nd:YAG laser is used to generate optical energy having a wavelength of about 1.32 micrometers.
Fig. 2 is a highly schematic representation of a laser surgical system for use in accordance with the invention. Laser 20 is preferably of the Nd:YAG crystalline variety wherein a yttrium-aluminum-garnet (YAG) rod is doped with Nd ions as the active light-producing element. As is known, laser 20 includes a resonant cavity for amplifying the emitted light and pumping means, such as a dc Krypton arc lamp, for supplying energy to create a population inversion of the normal energy state of Nd ions. Such a population inversion results in the stimulated emission of light in accordance with known laser principles.
Absent any tuning of the laser cavity, Nd:YAG lasers will always operate at a first and predominant mode of emission at a wavelength of approximately 1.06 micrometers. Nd:YAG lasers also emit light at a secondary wavelength of approximately 1.32 micrometers. Proper utilization of this secondary mode if laser operation requires the dominant emission, which has a greater amplitude than the secondary emission, to be suppressed. Typically, the peak power output at this secondary emission level is 20-30% of the continuous wave peak power output at the dominant level. It is the secondary wavelength that is utilized in the method and apparatus of the invention.
As readily understood by persons skilled in the art, laser 20 includes a power station for activiating the pumping arc lamp and cooling means for the laser. A suitable Nd:YAG laser for use in this invention is produced by Control Laser Corporation, which is presently located at 11222 Astronaut Boulevard, Orlando Florida 32809.
A lens 21 is provided to focus the emerging coherent light beam from laser 20 into an optical fiber 22. Lens 21 may comprise a system of lenses. Optical fiber 22 can be of any known type, which efficiently transmits the desired wavelength. Optical fiber 22 provides a flexible conduit for guiding the optical energy from the laser into a hand-piece 23 which is manipulable by the physician. A shutter 24 is located, preferably, between laser 20 and lens 21. Hand-piece 23 contains a shutter switch 25 which controls release of the laser energy and which may be actuated by either the hand or the foot of the operator. A timer 26 is provided to control the shutter and, thereby, the duration of energy exposure. Hand-piece 23 may include a lens for focusing or defocusing the beam.
Advantageously, hand-piece 23 includes means to enable the physician to set the working distance between the tissue to be irradiated and the distalmost end of the optical fiber of lens. In an illustrative embodiment, as shown in Fig. 3, a sliding scale 26 which cooperates with a protective case 27 on the end of the optical fiber 28 controls the working distance, and hence, the diameter of the beam spot. As shown in Fig. 3, the divergence of the beam is used to control the diameter as the distance between the distalmost end of the fiber and the tissue is increased or decreased.
The following electro-optical parameters require proper adjustment for each type of tissue: wavelength, spot or beam size, power, time exposure, and mode or beam geometry. In particular, the thermal effects on the tissue can be controlled by proper selection of the electro-optical parameters. Power density measures the energy concentration of the applied light beam and is typically expressed in watts per square centimeter area of the applied beam spot. Power density is directly related to the amount of heat that will be produced at a given absorptivity. If the wavelength of the applied beam is poorly absorbed, more heat can be generated by increasing the time of tissue exposure to the applied beam. Radiant exposure, expressed in joules per square centimeter, is a measure of the power density multiplied by the exposure time.
Means which are well known it the art are used to control the power output of laser 20. The power delivered to the tissue surface should be maintained under 10 watts for purposes of tissue reconstruction by laser 20 as described herein. The object is to deliver a specific amount of energy
O per volume of tissue. For a given spot size, which is related to the volume of tissue exposed, there are many combinations of power output and time exposure which will deliver equivalent amounts of energy. To wit, power delivered to the tissue typically ranges between 1 and 4 watts; although power delivered could go as high as 10 watts if the time exposure were reduced commensurately.
In the lowest order transmission mode, TE specific¬ ally, a more concentrated beam results which can be used for cutting purposes at higher power output or for achieving very small beam spot size for tissue reconstruction. In the alternative, multimode transmission can be used for tissue reconstruction, but the beam spot size can not be as finely focused as the TEMoo mode. However, it the beam is defocused, less power is delivered per unit area.
As will be understood, the selection of the various electro-optical parameters for each tissue type is made as a result of skill and experience; but is determinable without undue experimentation by one of ordinary skill in the art.
In a particularly advantageous embodiment, data relating to appropriate settings of electro-optical parameters for various tissue types can be coded on a computer memory device, such as floppy disc or programmable read-only memory computer chip. This control unit 40 can be provided to adjust automatically the time exposure, power level, and display the proper spot size upon input of tissue type and the operating conditions by the physician or surgeon.
A marker laser 30, illustratively a low-power helium-neon laser is coaligned with the infrared beam of the laser 20. Laser 30, however, can be of any type which emits radiation in the visible range of the electromagnetic spectrum. The power rating of the helium-neon marker laser 30 is between 1-5 mWatts. Marker laser 30 can be arranged so that its focal point coincides with that of the main operating laser 20 by any known technique.
As an optional feature, in order to permit the use of the laser apparatus of Fig. 2 on very thin tissue or tissue upon which only surface heating is desired, such as epineurium of
BSTITUTE SHEET nerve tissue, an auxiliary source of optical energy 50 can be incorporated into the apparatus to emit radiation having a wavelength which is intensely absorbed by biological tissue. A carbon dioxide laser, of any known type, would be a suitable auxiliary source. Source 50 is also preferrably arranged so as to have its output beam coincide with the beam from marker laser 30.
It should be further pointed out that the 1.06 micrometer wavelength of the Nd:YAG laser 20 can be selected by means which are all well known in the art for purposes of tissue coagulation and wound hemostasis, as desired.
In an illustrative embodiment, the apparatus of Fig. 2 is used for skin closure at a lesion site. The tissue edges of the lesion are brought into close approximation by manual manipulation, for example. Hand-piece 23 is positioned above the lesion at such a distance as to produce the desired beam spot size. The power, spot size, and time exposure are adjusted so as to heat the tissue above 45 degrees centigrade, but below the boiling point of water (100 degrees centigrade).
Typical spot sizes range from 0.1 mm to 1.0 mm for levels of power delivered to the tissue ranging from 1 to 5 watts, and time durations ranging from 0.05 to 5.0 seconds. When the optical energy of laser 20 at 1.32 micrometers is released on the lesion site, with the electro-optical parameters adjusted as hereinbefore suggested, the tissue at the lesion site is heated to a temperature sufficient to cause denaturization of the tissue proteins to the depth necessary to reconstruct the tissue in the lesion irrespective of whether the operating field is blody or wet. These same electro-optical parameters may be applied to the reconstruction of many soft tissues such as vascular structures, tendon, vas deferens, fallopian tubes, gastro-intestional tract, dura, and sclera. With a modification of the level of power delivered to the tissue under repair, cartilage and typanic membranes can be repaired in accordance with the invention described hereinabove.
The above-described embodiments are provided for the purpose of illustration and are not to be construed as limiting. Other modifications and adaptations can be made by
-^Ϊ those of skill in the art without departing from the spirit and scope of the invention. In particular, the laser energy can be transmitted to the patient treatment site by an articulated arm with mirrors or it can be transmitted to the interior of a patient by endoscope. Moreover, materials other than neodymium-doped crystalline yttrium-aluminum-garnet can be used as a lasing medium to generate optical energy at the desired wavelengths.

Claims

What is claimed is
1. A method of reconstructing biological tissue wherein a proteinaceous framework is formed from denatured protein in the vicinity of the tissue being reconstructed, which framework approximates the biological tissue being reconstructed, the method comprising the step of applying optical energy to the biological tissue at such a wavelength and at such power as to cause the amount of optical energy absorbed and converted to heat to be sufficient to raise the temperature of the biological tissue above ambient temperature, but below the boiling point of water, so as to cause the proteinaceous elements of the biological tissue to denature.
2. The method of claim 1 wherein said wavelength is in the range of 1.2 to 1.4 micrometers.
3. The method of claim 1 wherein said power is between 0 and 10 watts.
4. The method of claim 2, wherein said wavelength is about 1.32 micrometers and said step of applying comprises applying optical energy generated at a secondary wavelength of a Nd:YAG laser.
5. The method of healing a lesion in biological tissue of the type having proteinaceous elements, the method comprising the step of forming a seal at said lesion by applying optical energy having a wavelength from about 1.2 to 1.4 micrometers to said lesion so as to cause the proteinaceous elements of the biological tissue in the vicinity of said lesion to denature, thereby forming a collagenous seal at said lesion.
6. The method of claim 5 wherein the lesion comprises at least two segments of biological tissue and said method further comprises bringing said at least two segments of tissue into substantial communication prior to applying said optical energy.
7. The method of claim 5 wherein said optical energy is in the form of a monochromatic laser beam.
8. The method of claim 7 wherein said laser beam is generated by a Nd:YAG laser which is tuned to emit optical energy at its secondary wavelength of about 1.32 micrometers.
9. An arrangement for healing biological tissue, the arrangement comprising: an optical energy source for producing a beam of optical energy having a wavelength between approximately 1.2 and 1.4 micrometers; guide means for directing said beam of optical energy to a spot on the tissue, said guide means having a distalmost end from said optical energy source where said beam of optical energy is emitted; and control means for controlling the intensity of said optical energy to a level within a predetermined range wherein said biological tissue is denatured to produce a collagenous substance.
10. The arrangement of claim 9 wherein said guide means further include measurement means for determining a distance between said light-emitting end of said guide means and the tissue.
11. The arrangement of claim 9 wherein said guide means is further provided with a lens means located in the vicinity of said light-emitting end of said guide means and adapted to produce a predeterminable diameter of said spot on the tissue.
12. The arrangement of claim 9 wherein there is further provided marker means for producing a beam of visible optical energy concident with said emitted beam of optical energy whereby a region which is desired to be illuminated by said emitted beam of optical energy is identified.
13. The arrangement of claim 9 wherein said optical energy source is a Nd:YAG laser operated at a secondary wavelength of 1.32 micrometer.
14. The arrangement of claim 9 wherein there is further provided an auxiliary optical energy source.
15. The arrangement of claim 14 wherein said auxiliary optical energy source produces a beam of optical energy which has a wavelength which is substantially absorbed in biological tissue.
16. The arrangement of claim 15 wherein said auxiliary optical energy source comprises a Carbon Dioxide laser.
SUBSTITUTE SHEET
EP19840903838 1983-10-06 1984-10-05 Laser healing method and apparatus. Withdrawn EP0160667A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/539,527 US4672969A (en) 1983-10-06 1983-10-06 Laser healing method
US539527 2000-03-30

Publications (2)

Publication Number Publication Date
EP0160667A1 true EP0160667A1 (en) 1985-11-13
EP0160667A4 EP0160667A4 (en) 1987-07-22

Family

ID=24151601

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19840903838 Withdrawn EP0160667A4 (en) 1983-10-06 1984-10-05 Laser healing method and apparatus.

Country Status (4)

Country Link
US (1) US4672969A (en)
EP (1) EP0160667A4 (en)
JP (2) JPH078281B2 (en)
WO (1) WO1985001445A1 (en)

Families Citing this family (215)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409479A (en) * 1983-10-06 1995-04-25 Premier Laser Systems, Inc. Method for closing tissue wounds using radiative energy beams
US5140984A (en) * 1983-10-06 1992-08-25 Proclosure, Inc. Laser healing method and apparatus
US5019075A (en) * 1984-10-24 1991-05-28 The Beth Israel Hospital Method and apparatus for angioplasty
US5226430A (en) * 1984-10-24 1993-07-13 The Beth Israel Hospital Method for angioplasty
CA1262757A (en) * 1985-04-25 1989-11-07 Richard M. Dwyer Method and apparatus for laser surgery
AU602123B2 (en) * 1985-05-17 1990-10-04 Laser Holdings Limited Optical therapeutic and surgical system
US4672963A (en) * 1985-06-07 1987-06-16 Israel Barken Apparatus and method for computer controlled laser surgery
US4917084A (en) * 1985-07-31 1990-04-17 C. R. Bard, Inc. Infrared laser catheter system
US5196004A (en) * 1985-07-31 1993-03-23 C. R. Bard, Inc. Infrared laser catheter system
EP0214712B1 (en) * 1985-07-31 1992-09-02 C.R. Bard, Inc. Infrared laser catheter apparatus
US5336217A (en) * 1986-04-24 1994-08-09 Institut National De La Sante Et De La Recherche Medicale (Insepm) Process for treatment by irradiating an area of a body, and treatment apparatus usable in dermatology for the treatment of cutaneous angio dysplasias
JPS633873A (en) * 1986-06-23 1988-01-08 富士電機株式会社 Laser remedy device
DE3833991A1 (en) * 1987-05-25 1990-04-12 Messerschmitt Boelkow Blohm Catheter
DE8717812U1 (en) * 1987-09-02 1990-04-19 Schmidt, Rudolf, 8904 Friedberg, De
US4930504A (en) * 1987-11-13 1990-06-05 Diamantopoulos Costas A Device for biostimulation of tissue and method for treatment of tissue
US5053006A (en) * 1988-04-19 1991-10-01 Watson Brant D Method for the permanent occlusion of arteries
US5769840A (en) * 1988-04-19 1998-06-23 Schirmer; Kurt E. Microsurgery using alternating disruptive and thermal laser beam pulses
US5180304A (en) * 1988-08-25 1993-01-19 American Dental Laser, Inc. Method for apical fusion of the foramina
WO1990001906A1 (en) * 1988-08-25 1990-03-08 Arthur Vassiliadis Dental laser assembly
US4940411A (en) * 1988-08-25 1990-07-10 American Dental Laser, Inc. Dental laser method
US5324200A (en) * 1988-08-25 1994-06-28 American Dental Technologies, Inc. Method for enlarging and shaping a root canal
DE3831967C1 (en) * 1988-09-21 1990-02-08 Michael Dr. 7400 Tuebingen De Menton
US5147349A (en) * 1988-10-07 1992-09-15 Spectra-Physics, Inc. Diode laser device for photocoagulation of the retina
US4929246A (en) * 1988-10-27 1990-05-29 C. R. Bard, Inc. Method for closing and sealing an artery after removing a catheter
US5020995A (en) * 1989-01-18 1991-06-04 Guy Levy Surgical treatment method and instrument
US5885082A (en) * 1988-12-21 1999-03-23 Endo Technic International Corporation Dental and medical procedures employing laser radiation
US5009658A (en) * 1989-04-14 1991-04-23 Karl Storz Endoscopy-America, Inc. Dual frequency laser lithotripter
WO1991005515A1 (en) * 1989-10-19 1991-05-02 Australian Electro Optics Pty. Ltd. Fibre bundle coupled ophthalmic laser
US5257989A (en) * 1990-02-07 1993-11-02 Coherent, Inc. Contact laser delivery probe
US6162213A (en) * 1990-04-25 2000-12-19 Cincinnati Sub-Zero Products, Inc. Multiple wavelength metal vapor laser system for medical applications
US5066291A (en) * 1990-04-25 1991-11-19 Cincinnati Sub-Zero Products, Inc. Solid-state laser frequency conversion system
US5725522A (en) * 1990-06-15 1998-03-10 Rare Earth Medical, Inc. Laser suturing of biological materials
US5540677A (en) * 1990-06-15 1996-07-30 Rare Earth Medical, Inc. Endoscopic systems for photoreactive suturing of biological materials
US5071417A (en) * 1990-06-15 1991-12-10 Rare Earth Medical Lasers, Inc. Laser fusion of biological materials
US5292362A (en) * 1990-07-27 1994-03-08 The Trustees Of Columbia University In The City Of New York Tissue bonding and sealing composition and method of using the same
US5209776A (en) * 1990-07-27 1993-05-11 The Trustees Of Columbia University In The City Of New York Tissue bonding and sealing composition and method of using the same
ATE190733T1 (en) * 1990-08-01 2000-04-15 Diomed Ltd HIGH POWER LIGHT SOURCE
US5312396A (en) * 1990-09-06 1994-05-17 Massachusetts Institute Of Technology Pulsed laser system for the surgical removal of tissue
US5310344A (en) * 1990-11-01 1994-05-10 Arthur Vassiliadis Dental laser system
CA2103727A1 (en) * 1991-02-13 1992-08-14 Philip N. Sawyer Filler material for use in tissue welding
US5156613A (en) * 1991-02-13 1992-10-20 Interface Biomedical Laboratories Corp. Collagen welding rod material for use in tissue welding
US5669934A (en) * 1991-02-13 1997-09-23 Fusion Medical Technologies, Inc. Methods for joining tissue by applying radiofrequency energy to performed collagen films and sheets
US5749895A (en) * 1991-02-13 1998-05-12 Fusion Medical Technologies, Inc. Method for bonding or fusion of biological tissue and material
US5172264A (en) * 1991-02-21 1992-12-15 Surgilase, Inc. Method and apparatus for combining continuous wave laser with TEA pulsed laser
US5300063A (en) * 1991-05-11 1994-04-05 Nidek Co., Ltd. Ophthalmic laser apparatus
US5951596A (en) 1991-07-01 1999-09-14 Laser Biotherapy Inc Biological tissue stimulation by optical energy
US5445146A (en) 1995-03-31 1995-08-29 Bellinger; Gary J. Biological tissue stimulation by low level optical energy
USRE36872E (en) * 1992-01-15 2000-09-12 Laser Industries Ltd. System for causing ablation of irradiated material of living tissue while not causing damage below a predetermined depth
IL100664A0 (en) * 1992-01-15 1992-09-06 Laser Ind Ltd Method and apparatus for controlling a laser beam
US5290272A (en) * 1992-03-16 1994-03-01 Helios Inc. Method for the joining of ocular tissues using laser light
US5372585A (en) * 1992-04-09 1994-12-13 Tiefenbrun; Jonathan Instrument and associated method for applying biologically effective composition during laparoscopic operation
JPH07506991A (en) * 1992-04-23 1995-08-03 シメッド　ライフ　システムズ　インコーポレイテッド Apparatus and method for sealing vascular punctures
USRE40863E1 (en) * 1992-04-23 2009-07-21 Boston Scientific Scimed, Inc. Apparatus and method for sealing vascular punctures
US6063085A (en) * 1992-04-23 2000-05-16 Scimed Life Systems, Inc. Apparatus and method for sealing vascular punctures
US5810810A (en) * 1992-04-23 1998-09-22 Scimed Life Systems, Inc. Apparatus and method for sealing vascular punctures
US5334191A (en) * 1992-05-21 1994-08-02 Dix Phillip Poppas Laser tissue welding control system
US5390204A (en) * 1992-09-25 1995-02-14 Incisive Technologies, Inc. Intracavity modulated pulsed laser with a variably controllable modulation frequency
US5336221A (en) * 1992-10-14 1994-08-09 Premier Laser Systems, Inc. Method and apparatus for applying thermal energy to tissue using a clamp
US5290278A (en) * 1992-10-20 1994-03-01 Proclosure Inc. Method and apparatus for applying thermal energy to luminal tissue
US5354323A (en) * 1992-10-20 1994-10-11 Premier Laser Systems, Inc. Optical heating system
US5300065A (en) * 1992-11-06 1994-04-05 Proclosure Inc. Method and apparatus for simultaneously holding and sealing tissue
US5325393A (en) * 1992-11-06 1994-06-28 Carl Zeiss, Inc. Dual laser resonator and beam combiner
US5330974A (en) * 1993-03-01 1994-07-19 Fibratek, Inc. Therapeutic fibrinogen compositions
US5552452A (en) * 1993-03-15 1996-09-03 Arch Development Corp. Organic tissue glue for closure of wounds
US5588428A (en) * 1993-04-28 1996-12-31 The University Of Akron Method and apparatus for non-invasive volume and texture analysis
US5375132A (en) * 1993-05-05 1994-12-20 Coherent, Inc. Solid state laser with interleaved output
WO1994028972A1 (en) * 1993-05-14 1994-12-22 Eberhard Oppold Safety laser beam apertures (sla) for therapeutic and diagnostic medical equipment
US5571216A (en) * 1994-01-19 1996-11-05 The General Hospital Corporation Methods and apparatus for joining collagen-containing materials
US5591157A (en) * 1994-09-07 1997-01-07 Hennings; David R. Method and apparatus for tympanic membrane shrinkage
US5733278A (en) * 1994-11-30 1998-03-31 Laser Industries Limited Method and apparatus for hair transplantation using a scanning continuous-working CO2 laser
US5585007A (en) * 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant
US5480396A (en) * 1994-12-09 1996-01-02 Simon; Gabriel Laser beam ophthalmological surgery method and apparatus
AUPN066795A0 (en) * 1995-01-20 1995-02-16 Macquarie Research Limited Method of repair
US5624434A (en) * 1995-02-03 1997-04-29 Laser Industries, Ltd. Laser preparation of recipient holes for graft implantation in the treatment of icepick scars
US5817090A (en) * 1995-02-03 1998-10-06 Laser Industries, Ltd. Laser dermal implants for the treatment of facial skin depressions
US5611795A (en) * 1995-02-03 1997-03-18 Laser Industries, Ltd. Laser facial rejuvenation
US5634936A (en) * 1995-02-06 1997-06-03 Scimed Life Systems, Inc. Device for closing a septal defect
US5713891A (en) * 1995-06-02 1998-02-03 Children's Medical Center Corporation Modified solder for delivery of bioactive substances and methods of use thereof
DE19521003C1 (en) * 1995-06-08 1996-08-14 Baasel Carl Lasertech Pulsed light source for removing biological tissue
US5709677A (en) * 1995-07-12 1998-01-20 Laser Industries, Ltd. Apparatus and method as preparation for performing a myringotomy in a child's ear without the need for anaesthesia
US6475138B1 (en) 1995-07-12 2002-11-05 Laser Industries Ltd. Apparatus and method as preparation for performing a myringotomy in a child's ear without the need for anaesthesia
US5620435A (en) * 1995-10-05 1997-04-15 Optomedic Medical Technologies, Ltd. Eye surgery
WO1997013461A1 (en) * 1995-10-11 1997-04-17 Fusion Medical Technologies, Inc. Device and method for sealing tissue
US7141049B2 (en) * 1999-03-09 2006-11-28 Thermage, Inc. Handpiece for treatment of tissue
US7452358B2 (en) 1996-01-05 2008-11-18 Thermage, Inc. RF electrode assembly for handpiece
US7229436B2 (en) * 1996-01-05 2007-06-12 Thermage, Inc. Method and kit for treatment of tissue
US7473251B2 (en) 1996-01-05 2009-01-06 Thermage, Inc. Methods for creating tissue effect utilizing electromagnetic energy and a reverse thermal gradient
US20030212393A1 (en) 1996-01-05 2003-11-13 Knowlton Edward W. Handpiece with RF electrode and non-volatile memory
US5662644A (en) * 1996-05-14 1997-09-02 Mdlt, Inc. Dermatological laser apparatus and method
US6063108A (en) 1997-01-06 2000-05-16 Salansky; Norman Method and apparatus for localized low energy photon therapy (LEPT)
US5810801A (en) * 1997-02-05 1998-09-22 Candela Corporation Method and apparatus for treating wrinkles in skin using radiation
US5957919A (en) * 1997-07-02 1999-09-28 Laufer; Michael D. Bleb reducer
LT4411B (en) 1997-10-30 1998-11-25 Laser Biotherapy, Inc. Device for stimulation biological tissue by optical energy
US6221068B1 (en) * 1998-01-15 2001-04-24 Northwestern University Method for welding tissue
US6575964B1 (en) 1998-02-03 2003-06-10 Sciton, Inc. Selective aperture for laser delivery system for providing incision, tissue ablation and coagulation
US6120498A (en) * 1998-03-05 2000-09-19 Jani; Mahendra G. Aspirating handpieces for laser surgical operations
FR2781358B1 (en) * 1998-07-27 2000-10-13 Cird Galderma DEVICE FOR ASSEMBLING LIPS FROM A WOUND, HOLDING PIECE AND COSMETIC TREATMENT METHOD
US6428532B1 (en) * 1998-12-30 2002-08-06 The General Hospital Corporation Selective tissue targeting by difference frequency of two wavelengths
US6692517B2 (en) * 1999-01-15 2004-02-17 Cynosure, Inc. Optical radiation treatment for enhancement of wound healing
US6210426B1 (en) * 1999-01-15 2001-04-03 Cynosure Inc Optical radiation treatment for prevention of surgical scars
JP4084903B2 (en) * 1999-04-14 2008-04-30 株式会社オプトン Far infrared heating device
AU1122001A (en) 1999-11-01 2001-05-14 Philip W. Passy Miniature cluster laser therapy device
US6682216B1 (en) * 1999-12-16 2004-01-27 The Regents Of The University Of California Single-fiber multi-color pyrometry
US6451010B1 (en) * 2000-04-14 2002-09-17 Lumenis Inc. Zoom handpiece for laser surgery
US6569156B1 (en) * 2000-06-30 2003-05-27 Nikolai Tankovich Medical cosmetic laser with second wavelength enhancement
US8251986B2 (en) 2000-08-17 2012-08-28 Angiodynamics, Inc. Method of destroying tissue cells by eletroporation
US6743221B1 (en) 2001-03-13 2004-06-01 James L. Hobart Laser system and method for treatment of biological tissues
CN1524272A (en) 2001-05-03 2004-08-25 �����ι�˾ Differential photochemical & photomechamical processing
US6770069B1 (en) 2001-06-22 2004-08-03 Sciton, Inc. Laser applicator
US6858114B2 (en) 2001-07-03 2005-02-22 The University Of Alabama Laser hydrolysis of polypeptides
US6994706B2 (en) 2001-08-13 2006-02-07 Minnesota Medical Physics, Llc Apparatus and method for treatment of benign prostatic hyperplasia
WO2003026481A2 (en) 2001-09-26 2003-04-03 Rice University Optically-absorbing nanoparticles for enhanced tissue repair
DE10158519B4 (en) * 2001-11-29 2005-01-13 Dornier Medtech Holding International Gmbh Shock and shock wave therapy device
US20040082940A1 (en) * 2002-10-22 2004-04-29 Michael Black Dermatological apparatus and method
EP2404555B1 (en) * 2002-04-16 2017-03-15 Covidien LP Surgical stapler and method
US7179391B2 (en) 2002-05-24 2007-02-20 Biomet Manufacturing Corp. Apparatus and method for separating and concentrating fluids containing multiple components
US7374678B2 (en) 2002-05-24 2008-05-20 Biomet Biologics, Inc. Apparatus and method for separating and concentrating fluids containing multiple components
US20080177359A1 (en) * 2002-05-03 2008-07-24 Advanced Light Technology, Llc. Differential photochemical and photomechanical processing
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7431730B2 (en) * 2002-05-10 2008-10-07 Tyco Healthcare Group Lp Surgical stapling apparatus having a wound closure material applicator assembly
CA2484635C (en) * 2002-05-10 2011-01-04 Tyco Healthcare Group Lp Electrosurgical stapling apparatus
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
DE10234144A1 (en) * 2002-07-26 2004-02-05 Dornier Medtech Gmbh lithotripter
JP2006507046A (en) * 2002-10-31 2006-03-02 クールタッチ， インコーポレイテッド Intravenous closure of varicose veins by mid-infrared laser
US6866678B2 (en) 2002-12-10 2005-03-15 Interbational Technology Center Phototherapeutic treatment methods and apparatus
US7223266B2 (en) 2003-02-04 2007-05-29 Cardiodex Ltd. Methods and apparatus for hemostasis following arterial catheterization
US20070265606A1 (en) * 2003-02-14 2007-11-15 Reliant Technologies, Inc. Method and Apparatus for Fractional Light-based Treatment of Obstructive Sleep Apnea
US7354433B2 (en) * 2003-02-28 2008-04-08 Advanced Light Technologies, Llc Disinfection, destruction of neoplastic growth, and sterilization by differential absorption of electromagnetic energy
US20110040295A1 (en) * 2003-02-28 2011-02-17 Photometics, Inc. Cancer treatment using selective photo-apoptosis
EP1613202B1 (en) 2003-03-27 2011-02-09 The General Hospital Corporation Apparatus for dermatological treatment and fractional skin resurfacing
US7220778B2 (en) * 2003-04-15 2007-05-22 The General Hospital Corporation Methods and devices for epithelial protection during photodynamic therapy
US7090670B2 (en) * 2003-12-31 2006-08-15 Reliant Technologies, Inc. Multi-spot laser surgical apparatus and method
WO2005096783A2 (en) * 2004-04-08 2005-10-20 Omniguide, Inc. Photonic crystal fibers and medical systems including photonic crystal
US7349589B2 (en) * 2004-04-08 2008-03-25 Omniguide, Inc. Photonic crystal fibers and medical systems including photonic crystal fibers
US7331954B2 (en) 2004-04-08 2008-02-19 Omniguide, Inc. Photonic crystal fibers and medical systems including photonic crystal fibers
US7167622B2 (en) * 2004-04-08 2007-01-23 Omniguide, Inc. Photonic crystal fibers and medical systems including photonic crystal fibers
US7413572B2 (en) * 2004-06-14 2008-08-19 Reliant Technologies, Inc. Adaptive control of optical pulses for laser medicine
US7455682B2 (en) * 2004-10-18 2008-11-25 Tyco Healthcare Group Lp Structure containing wound treatment material
JP5068662B2 (en) 2004-11-22 2012-11-07 カーディオデックス リミテッド Heat treatment technology for varicose veins
EP1671627B8 (en) * 2004-12-15 2010-04-07 Dornier MedTech Systems GmbH Improvement of cell therapy and tissue regeneration in patients with cardiovascular and neurological diseases by means of shockwaves
US7866485B2 (en) 2005-02-07 2011-01-11 Hanuman, Llc Apparatus and method for preparing platelet rich plasma and concentrates thereof
EP1848474B1 (en) 2005-02-07 2013-06-12 Hanuman LLC Platelet rich plasma concentrate apparatus and method
ES2426941T3 (en) 2005-02-07 2013-10-25 Hanuman Llc Apparatus and procedure of platelet rich plasma concentrates
US20060241495A1 (en) * 2005-03-23 2006-10-26 Eastman Kodak Company Wound healing monitoring and treatment
US20060217787A1 (en) * 2005-03-23 2006-09-28 Eastman Kodak Company Light therapy device
US8357146B2 (en) * 2005-05-18 2013-01-22 Cooltouch Incorporated Treatment of cellulite and adipose tissue with mid-infrared radiation
US8276590B2 (en) 2005-05-18 2012-10-02 Cooltouch Incorporated Thermally mediated tissue molding
US20070021807A1 (en) * 2005-07-20 2007-01-25 Eastman Kodak Company Device for optically stimulating collagen formation in tissue
DE102005037043C5 (en) * 2005-08-05 2017-12-14 Dornier Medtech Systems Gmbh Shock wave therapy device with image acquisition
JP2007089875A (en) * 2005-09-29 2007-04-12 Matsushita Electric Ind Co Ltd Laser therapy apparatus
US8033284B2 (en) * 2006-01-11 2011-10-11 Curaelase, Inc. Therapeutic laser treatment
DE102006002273A1 (en) * 2006-01-17 2007-07-26 Dornier Medtech Systems Gmbh treatment facility
US20070212335A1 (en) * 2006-03-07 2007-09-13 Hantash Basil M Treatment of alopecia by micropore delivery of stem cells
US20070233208A1 (en) * 2006-03-28 2007-10-04 Eastman Kodak Company Light therapy bandage with imbedded emitters
US20070264626A1 (en) * 2006-05-11 2007-11-15 Reliant Technologies, Inc. Apparatus and Method for a Combination of Ablative and Nonablative Dermatological Treatment
WO2007134256A2 (en) * 2006-05-11 2007-11-22 Reliant Technologies, Inc. Apparatus and method for ablation-related dermatological treatment of selected targets
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8246611B2 (en) * 2006-06-14 2012-08-21 Candela Corporation Treatment of skin by spatial modulation of thermal heating
US7806276B2 (en) 2007-04-12 2010-10-05 Hanuman, Llc Buoy suspension fractionation system
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
US8251983B2 (en) * 2007-05-14 2012-08-28 The Regents Of The University Of Colorado, A Body Corporate Laser tissue fusion of septal membranes
EP2164418B1 (en) * 2007-06-27 2014-01-08 The General Hospital Corporation Apparatus for optical inhibition of photodynamic therapy
US8366706B2 (en) 2007-08-15 2013-02-05 Cardiodex, Ltd. Systems and methods for puncture closure
EP2259774B1 (en) 2008-02-27 2012-12-12 Biomet Biologics, LLC Methods and compositions for delivering interleukin-1 receptor antagonist
WO2009111338A1 (en) 2008-02-29 2009-09-11 Biomet Manufacturing Corp. A system and process for separating a material
US9078617B2 (en) * 2008-03-17 2015-07-14 Or-Nim Medical Ltd. Apparatus for non-invasive optical monitoring
US9283051B2 (en) 2008-04-29 2016-03-15 Virginia Tech Intellectual Properties, Inc. System and method for estimating a treatment volume for administering electrical-energy based therapies
US9198733B2 (en) 2008-04-29 2015-12-01 Virginia Tech Intellectual Properties, Inc. Treatment planning for electroporation-based therapies
US11272979B2 (en) 2008-04-29 2022-03-15 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
US10245098B2 (en) 2008-04-29 2019-04-02 Virginia Tech Intellectual Properties, Inc. Acute blood-brain barrier disruption using electrical energy based therapy
US8992517B2 (en) 2008-04-29 2015-03-31 Virginia Tech Intellectual Properties Inc. Irreversible electroporation to treat aberrant cell masses
US11254926B2 (en) 2008-04-29 2022-02-22 Virginia Tech Intellectual Properties, Inc. Devices and methods for high frequency electroporation
US9867652B2 (en) 2008-04-29 2018-01-16 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
US10117707B2 (en) 2008-04-29 2018-11-06 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
EP2280741A4 (en) 2008-04-29 2012-06-13 Virginia Tech Intell Prop Irreversible electroporation to create tissue scaffolds
US10238447B2 (en) 2008-04-29 2019-03-26 Virginia Tech Intellectual Properties, Inc. System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress
US10272178B2 (en) 2008-04-29 2019-04-30 Virginia Tech Intellectual Properties Inc. Methods for blood-brain barrier disruption using electrical energy
US10702326B2 (en) 2011-07-15 2020-07-07 Virginia Tech Intellectual Properties, Inc. Device and method for electroporation based treatment of stenosis of a tubular body part
US8012077B2 (en) 2008-05-23 2011-09-06 Biomet Biologics, Llc Blood separating device
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8632534B2 (en) * 2009-04-03 2014-01-21 Angiodynamics, Inc. Irreversible electroporation (IRE) for congestive obstructive pulmonary disease (COPD)
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US11638603B2 (en) 2009-04-09 2023-05-02 Virginia Tech Intellectual Properties, Inc. Selective modulation of intracellular effects of cells using pulsed electric fields
US11382681B2 (en) 2009-04-09 2022-07-12 Virginia Tech Intellectual Properties, Inc. Device and methods for delivery of high frequency electrical pulses for non-thermal ablation
US8903488B2 (en) 2009-05-28 2014-12-02 Angiodynamics, Inc. System and method for synchronizing energy delivery to the cardiac rhythm
US9895189B2 (en) 2009-06-19 2018-02-20 Angiodynamics, Inc. Methods of sterilization and treating infection using irreversible electroporation
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
WO2011015205A1 (en) * 2009-08-03 2011-02-10 Wavelight Gmbh Einrichtung für die laserchirurgische ophthalmologie
US9063299B2 (en) 2009-12-15 2015-06-23 Omni Guide, Inc. Two-part surgical waveguide
US20110172746A1 (en) * 2010-01-12 2011-07-14 Roger Porter High Level Laser Therapy Apparatus and Methods
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
JP5641773B2 (en) * 2010-04-28 2014-12-17 キヤノン株式会社 measuring device
WO2012051433A2 (en) 2010-10-13 2012-04-19 Angiodynamics, Inc. System and method for electrically ablating tissue of a patient
WO2012088149A2 (en) 2010-12-20 2012-06-28 Virginia Tech Intellectual Properties, Inc. High-frequency electroporation for cancer therapy
US9078665B2 (en) 2011-09-28 2015-07-14 Angiodynamics, Inc. Multiple treatment zone ablation probe
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9888956B2 (en) 2013-01-22 2018-02-13 Angiodynamics, Inc. Integrated pump and generator device and method of use
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
WO2015175570A1 (en) 2014-05-12 2015-11-19 Virginia Tech Intellectual Properties, Inc. Selective modulation of intracellular effects of cells using pulsed electric fields
US9907975B1 (en) 2014-11-19 2018-03-06 Roger D. Porter Therapeutic laser treatment and transdermal stimulation of stem cell differentiation
US10694972B2 (en) 2014-12-15 2020-06-30 Virginia Tech Intellectual Properties, Inc. Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment
EP3067005B1 (en) * 2015-03-13 2017-11-08 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Laser surgery apparatus for contact laser surgery
US9713810B2 (en) 2015-03-30 2017-07-25 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US9757721B2 (en) 2015-05-11 2017-09-12 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US10905492B2 (en) 2016-11-17 2021-02-02 Angiodynamics, Inc. Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode
US11607537B2 (en) 2017-12-05 2023-03-21 Virginia Tech Intellectual Properties, Inc. Method for treating neurological disorders, including tumors, with electroporation
US11311329B2 (en) 2018-03-13 2022-04-26 Virginia Tech Intellectual Properties, Inc. Treatment planning for immunotherapy based treatments using non-thermal ablation techniques
US11925405B2 (en) 2018-03-13 2024-03-12 Virginia Tech Intellectual Properties, Inc. Treatment planning system for immunotherapy enhancement via non-thermal ablation

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3750670A (en) * 1970-08-03 1973-08-07 Medoptics Inc Laser cauterizer
DE2809007A1 (en) * 1978-03-02 1979-09-13 Messerschmitt Boelkow Blohm Live tissue cutting and coagulating instrument - has two different wavelength laser beams and pilot light(s) passed together through manipulator to emerge coaxially from it
FR2494986A1 (en) * 1980-11-04 1982-06-04 Agency Ind Science Techn LASER BISTOURI
EP0075860A2 (en) * 1981-09-24 1983-04-06 James Robert Morris Microsurgical laser
DE3242612A1 (en) * 1981-11-19 1983-05-26 Nippon Infrared Industries Co., Ltd., Tokyo LASER BEAM DEVICE

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3467098A (en) * 1967-03-24 1969-09-16 Becton Dickinson Co Flexible conduit for laser surgery
US3817619A (en) * 1967-08-08 1974-06-18 Olympus Optical Co Device for measuring distance of an object from the forward end portion of an endoscope
US3769963A (en) * 1972-03-31 1973-11-06 L Goldman Instrument for performing laser micro-surgery and diagnostic transillumination of living human tissue
JPS5145911A (en) * 1974-10-17 1976-04-19 Matsushita Electric Ind Co Ltd TEREBIJON JUZOKI
SU618116A1 (en) * 1975-01-24 1978-08-05 Предприятие П/Я Г-4147 Method of connecting the tissues of hollow organs
JPS6058970B2 (en) * 1978-07-27 1985-12-23 旭光学工業株式会社 Laser scalpel device
JPS5552750A (en) * 1978-10-12 1980-04-17 Mochida Pharm Co Ltd Laser knife* which can be detected* of tumor portion
SU886907A1 (en) * 1980-01-04 1981-12-07 Московский Городской Ордена Ленина И Ордена Трудового Красного Знамени Научно-Исследовательский Институт Скорой Помощи Им.Н.В.Склифосовского Method of treating burns
US4408602A (en) * 1981-01-14 1983-10-11 Asahi Kogaku Kogyo Kabushiki Kaisha Laser knife device
US4461295A (en) * 1983-10-21 1984-07-24 Herrick Robert S Laser punctal occlusion
CA2054149A1 (en) * 1990-10-29 1992-04-30 Eric Pringault Villin gene promoter sequence and its use in vectors, transformed mammalian cell lines, transgenic animals, and cell lines derived from the animals

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3750670A (en) * 1970-08-03 1973-08-07 Medoptics Inc Laser cauterizer
DE2809007A1 (en) * 1978-03-02 1979-09-13 Messerschmitt Boelkow Blohm Live tissue cutting and coagulating instrument - has two different wavelength laser beams and pilot light(s) passed together through manipulator to emerge coaxially from it
FR2494986A1 (en) * 1980-11-04 1982-06-04 Agency Ind Science Techn LASER BISTOURI
EP0075860A2 (en) * 1981-09-24 1983-04-06 James Robert Morris Microsurgical laser
DE3242612A1 (en) * 1981-11-19 1983-05-26 Nippon Infrared Industries Co., Ltd., Tokyo LASER BEAM DEVICE

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO8501445A1 *

Also Published As

Publication number Publication date
JPS61500104A (en) 1986-01-23
JPH078281B2 (en) 1995-02-01
JP2895436B2 (en) 1999-05-24
EP0160667A4 (en) 1987-07-22
JPH09271477A (en) 1997-10-21
WO1985001445A1 (en) 1985-04-11
US4672969A (en) 1987-06-16

Similar Documents

Publication Publication Date Title
US4672969A (en) Laser healing method
US5140984A (en) Laser healing method and apparatus
US5002051A (en) Method for closing tissue wounds using radiative energy beams
US4854320A (en) Laser healing method and apparatus
US5409479A (en) Method for closing tissue wounds using radiative energy beams
US4791927A (en) Dual-wavelength laser scalpel background of the invention
JP3245426B2 (en) Alexandrite laser system for treating dermatological specimens
US5290272A (en) Method for the joining of ocular tissues using laser light
AU695487B2 (en) Biological tissue stimulation by optical energy
Hendrick et al. Wound healing after laser surgery
CA2278316A1 (en) Biological tissue stimulation by optical energy
EP0165301B1 (en) Excimer laser for medical treatment on organic tissue in biolocical systems at a pathological situs
Scherr et al. Laser tissue welding
Bass et al. Sutureless microvascular anastomosis using the THC: YAG laser: a preliminary report
Treat et al. New technologies and future applications of surgical lasers: The right tool for the right job
Savage et al. NIR laser tissue welding of in vitro porcine cornea and sclera tissue
Pini et al. Laser tissue welding in minimally invasive surgery and microsurgery
Trabucchi et al. Laser welding of corneal tissue: preliminary experiences using 810nm and 1950nm diode lasers
Strassman et al. Laser soldering of the cornea in a rabbit model using a controlled-temperature CO2 laser system
KR101769712B1 (en) Laser Surgery Device For Bloodless Resection
Hanna et al. Laser welding of fascial grafts and its potential application in tympanoplasty: an animal model
Smith et al. New trends in carbon dioxide laser microsurgery
Dew Review and status report on laser tissue sealing: 1990
Van Swol et al. Optimization of dosimetry and safety using the holmium laser for urology
Tabakoğlu et al. Therapeutic lasers and skin welding applications

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19850520

AK Designated contracting states

Designated state(s): AT BE CH DE FR GB LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19870722

17Q First examination report despatched

Effective date: 19890629

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19900530

RIN1 Information on inventor provided before grant (corrected)

Inventor name: DEW, DOUGLAS, K.